drugset
drugset / Trial / NCT02927626

Yang Yin Fu Zheng Therapy in HBV Associated Hepatocellular Carcinoma

NCT02927626 ↗

Phase 0 Completed 132 enrolled Beijing Ditan Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Clinical research of Yang Yin Fu Zheng therapy in HBV associated hepatocellular carcinoma basing on immune microenviroment.The purpose of this study is to observe the efficacy of routine medical care combined with Yang Yin Fu Zheng therapy for patients belong to HBV-HCC.

Timeline

Start
2016-08
Primary completion
2018-12
Completion
2018-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Yang Yin Fu Zheng Traditional medicine (herbal / TCM) — —

Indications

hepatocellular carcinoma